Skip to main content
Christopher Barbieri, MD, Urology, New York, NY

Christopher E Barbieri MD PhD

Surgical Oncology


Peter M. Sacerdote Distinguished Associate Professor in Urologic Oncology Weill Cornell Medicine

Request appointment
  • 525 East 68th StreetStarr 900New York, NY 10065

  • Book by Phone+1(507) 501-7845

Overview of  Dr. Barbieri

Dr. Christopher Barbieri is a urologist based in New York, specializing in surgical oncology. He completed his medical education at Vanderbilt University, followed by residencies in surgery and urology at New York Presbyterian Hospital. Dr. Barbieri currently serves as an Attending Surgeon at New York-Presbyterian Hospital and Professor at Weill Cornell Medicine. His clinical expertise includes prostatectomy, robotic surgery, urologic oncology, genomics and genetics, and minimally invasive urologic surgery. He has authored multiple publications, with his research contributing to understanding prostate cancer. Dr. Barbieri has been recognized with several awards, including the MetLife Clinical Investigator Award and a Rising Star in Urology Research designation.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2009 - 2013
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2007

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2028
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
  • MetLife Clinical Investigator Award Damon Runyon Cancer Research Foundation, 2016

Publications & Presentations

PubMed

Journal Articles

  • Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation Rates  
    Christopher E Barbieri, James A Kashanian, The Journal of Sexual Medicine
  • Introduction to “Molecular Drivers of Prostate Cancer Development, Progression, and Resistance to Therapy”  
    Christopher Barbieri, MD, Urologic Oncology
  • Molecular Subtypes of Prostate Cancer  
    Christopher Barbieri, MD, Current Oncology Reports

Authored Content

  • SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone SensitivityMarch 2018

Press Mentions

  • Putting the Brakes on Prostate Cancer Cells
    Putting the Brakes on Prostate Cancer CellsDecember 13th, 2024
  • What You Need to Know About Prostate Cancer Treatments
    What You Need to Know About Prostate Cancer TreatmentsOctober 7th, 2024
  • Prostate Cancer’s Spread Modeled with CRISPR Barcoding Technology
    Prostate Cancer’s Spread Modeled with CRISPR Barcoding TechnologySeptember 23rd, 2024

Grant Support

  • The role of early oncogenic drivers in maintaining lineage fidelity in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2025–2030
  • Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2025–2030
  • Upstream and downstream targeting of the SPOP ubiquitin signaling pathway in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2024–2029
  • Collaborative genomic alterations and transcriptional control in prostate cancerWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
  • Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate CancerWEILL MEDICAL COLL OF CORNELL UNIV2018–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: